Department of Information Technology , University of Borås , SE-501 90 Borås , Sweden.
Discovery Sciences , AstraZeneca IMED Biotech Unit , SE-431 83 Mölndal , Sweden.
J Chem Inf Model. 2019 Mar 25;59(3):1230-1237. doi: 10.1021/acs.jcim.8b00724. Epub 2019 Feb 22.
Iterative screening has emerged as a promising approach to increase the efficiency of high-throughput screening (HTS) campaigns in drug discovery. By learning from a subset of the compound library, inferences on what compounds to screen next can be made by predictive models. One of the challenges of iterative screening is to decide how many iterations to perform. This is mainly related to difficulties in estimating the prospective hit rate in any given iteration. In this article, a novel method based on Venn-ABERS predictors is proposed. The method provides accurate estimates of the number of hits retrieved in any given iteration during an HTS campaign. The estimates provide the necessary information to support the decision on the number of iterations needed to maximize the screening outcome. Thus, this method offers a prospective screening strategy for early-stage drug discovery.
迭代筛选已成为提高药物发现高通量筛选 (HTS) 效率的一种有前途的方法。通过从化合物库的一个子集学习,可以通过预测模型推断出接下来要筛选哪些化合物。迭代筛选的一个挑战是决定要执行多少次迭代。这主要与在任何给定迭代中估计预期命中率的困难有关。在本文中,提出了一种基于 Venn-ABERS 预测器的新方法。该方法可准确估计在 HTS 实验中任何给定迭代中检索到的命中数。这些估计提供了必要的信息,以支持关于需要进行多少次迭代以最大化筛选结果的决策。因此,该方法为早期药物发现提供了一种前瞻性筛选策略。